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Abstract
Purpose A series of 100 children under 2 years of age
treated for hydrocephalus is described. All patients received
a standard differential low-pressure (SD low) valve as the
first cerebrospinal fluid (CSF) shunt treatment. The perfor-
mance of this group during follow-up is analysed.
Methods A retrospective cohort study was performed using
the intern electronic health record from our hospital. Chil-
dren younger than 2 years who underwent initial CSF shunt
treatment with a SD low valve between 1998 and 2008 were
eligible.
Results Mean follow-up was 7 years. The majority of 81%
(81 of 100) of the children did not receive an upgrade of
pressure profile throughout follow-up. The first revision was
done after a mean of 456 days (median, 64 days; min, 3; and
max, 4,183). The 1-year survival rate of the CSF shunt in
this cohort was 42%. In the relatively large group of mye-
lomeningocele patients (37 of 100), only one patient devel-
oped symptomatic overdrainage. A total of 9% (9 of 100) of
the children presented with symptoms of overdrainage. In
3% (3 out of 100) of these children, symptoms of over-
drainage persisted, in spite of multiple valve mutations.
During the total follow-up, 26% (26 of 100) of the patients
had never received shunt revision surgery. Fifteen percent
(15 of 100) of the children developed a shunt infection
within the first year.
Conclusions The use of SD low valves in the youngest age
group is effective in the majority of children. The aetiology
of myelomeningocele appears to protect the patient from
symptomatic overdrainage.
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Introduction
Hydrocephalus can be defined as an active distension of the
ventricular system of the brain resulting from inadequate
passage of cerebrospinal fluid (CSF) from its point of pro-
duction within the cerebral ventricles to its point of absorp-
tion into the systemic circulation (i.e. triventricular and
communicating hydrocephalus respectively) [11]. The for-
mer is often related to an obstruction between the third and
fourth ventricles while the latter does not show any mor-
phological obstructions. The aetiology of hydrocephalus
varies, and a MRI scan is important to define its cause.
The overall incidence of infantile hydrocephalus is about
0.66 per 1,000 live births [8].
The most common treatment for the hydrocephalus in
infants is the insertion of a CSF shunt. The alternative
treatment of endoscopic third ventriculostomy (ETV) in
cases of triventricular hydrocephalus is controversial in this
youngest age group [3]. Therefore, CSF shunt insertion is
considered standard treatment especially in young children.
The adverse effects of CSF shunts are well recognized, and
a shunt dysfunction is a common problem in neurosurgery.
Many different types of shunts have been designed to over-
come these problems, but the ideal shunt still does not exist.
The shunt trial has shown that different types of valves show
comparable outcomes [4, 6]. The number of different valves
has been increasing ever since, but basically, these valves
can be distinguished according to the differential pressure
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We describe a series of children (n0100) who all re-
ceived a standard differential low-pressure (SD low) valve
as first shunt treatment. This treatment policy is based on the
hypothesis that as long as the sutures of the skull have not
closed, the intracranial pressure will be low.
The overall characteristics of this cohort are analysed
concerning aetiology and shunt survival rates. A more de-
tailed analysis is presented of a subcategory of patients with
serious overdrainage problems. The potential relationship
between symptomatic overdrainage and the implantation of
SD low valves is analysed and discussed.
Methods
Study design
The present retrospective study was approved by the Med-
ical Ethical Committee of University Hospital Groningen
(UMCG), the Netherlands. After informed consent of the
parents, we investigated a retrospective cohort of children
under the age of 2 years who primary received a CSF shunt
with a SD low valve. All patients were treated within the
period from 1998 to 2008, at UMCG. A total of 112 patients
were treated with a CSF shunt during the period of inclu-
sion. The initial treatment of 12 patients was with a SD
medium-pressure valve; thesew e r ee x c l u d e df r o mt h i s
study. Mean follow-up was 7 years.
Children from northern parts of the Netherlands are re-
ferred to our clinic. The total population of this area is about
1.7 million. All procedures were performed by a neurosur-
geon or resident under supervision of a neurosurgeon.
The standard treatment of hydrocephalus in this young
age group has been CSF shunt implantation using a SD low
valve (PS Medical Low). This valve has an opening pressure
of 5 cm CSF without an anti-siphoning device. Patients are
followed by a paediatric neurologist. In the case of a sus-
pected dysfunction, patients are referred to the neurosurgery
department. Shunt failure was diagnosed after both clinical
and radiological criteria. We identified overdrainage when
this was indicated by MRI and explicitly clinically conclud-
ed in the medical record of the child.
Data collection
We analysed the patient records of all 100 cases concerning
basic patient characteristics, aetiology of the hydrocephalus,
secondary diagnoses, the dates on which the interventions
where made and the type of shunt (including the pressure
profile, the type of CSF diversion, cause of shunt dysfunc-
tion). Two different groups were identified. The first group
contained all children who received an upgrade of the pres-
sure profile (group 1), and the second group did not receive
any upgrade (group 2). Group 1 was subdivided into two
categories, i.e. category 1A (symptomatic group) that re-
ceived an upgrade for overdrainage symptoms and group 1B
(non-symptomatic group) that received an upgrade for shunt
dysfunction without symptoms of overdrainage. The
upgrading of the pressure profile in group 1B was per-
formed during shunt revision surgery irrespective of the
cause of shunt malfunction but in the absence of
symptomatic overdrainage often as an additional act based
on personal judgement of the neurosurgeon. No definite
guidelines concerning hydrocephalus treatment in general
or preference in the type of valve in particular were available
at that time. Patients of category 1Awere further subdivided
between cases with resolved or persistent overdrainage
symptoms after upgrading. Analysis took place in Septem-
ber 2010; SPSS 16.0 was used for the processing of data.
Results
SomeofthecharacteristicsofthiscohortareshowninTables1
and2. The meanfollow-up was 7 years.The first revisionwas
done after a mean of 456 days (median, 64 days; min, 3; and
max, 4,183). Most common complications are proximal shunt
obstruction and infection. Revision surgery is carried out for
shunt obstruction, malposition, overdrainage, or infection.
During the first year after the initial placement of the CSF
shunt, 58 out of 100 patients needed revision surgery of the
CSF shunt.So the 1-year survivalrateofthe CSFshunt inthis
cohort was 42% Fig 1. During the total follow-up, 26% (26 of
100) of the patients had never received shunt revision surgery.
In the course of the first year, 15% (15 of 100) of the patients
developed a shunt infection. A total of 35 patients received
other treatments for hydrocephalus prior to the insertion of a
CSF shunt, including external ventricular drain, Ommaya
reservoir, ETVor a combination of these.
Group 1A consisted of patients with overdrainage symp-
toms, which resulted in an upgrade of the pressure profile of
the valve from SD low to SD medium. Nine percent (9 of
100) of the patients presented with overdrainage symptoms.
In 6% (6 of 100) of the patients, the upgrade from a SD low-
pressure valve to a SD medium-pressure valve resulted in
adequate drainage. In the remaining 3% (3 of 100) of the
patients, symptoms of overdrainage persisted.
Group 1B involved patients without symptoms of over-
drainage, who received an upgrade from a SD low valve to a
SD medium valve during surgery for shunt dysfunction.
There was no clear indication for upgrading in these
patients, but the decision was made for various reasons often
not specified and based on personal judgement of the
neurosurgeon.
470 Childs Nerv Syst (2012) 28:469–473One patient became shunt independent during the follow-
up period. Eleven patients died during follow-up. The mean
age at death was 614 days (median, 399 days; min, 19; max,
1,646). One patient died of shunt dysfunction. Due to a
delayed referral, the patient developed increased intracranial
pressure with subsequent irreversible brain damage. Anoth-
er patient died of haemolytic–uremic syndrome after men-
ingitis. The remaining nine patients died of causes not
related to shunt dysfunction.
Discussion
After a mean follow-up period of 7 years, 81% (81 of 100)
of the patients were adequately treated with SD low shunts.
No symptoms of overdrainage were recorded in these
patients. Ten patients without symptoms of overdrainage
received upgrading of the SD valves from low to medium
pressure during shunt dysfunction surgery irrespective of the
cause of shunt malfunction as an additional act based on
personal judgement of the neurosurgeon. It remains uncer-
tain whether this intervention contributed to the prevention
of symptomatic overdrainage or not.
The other nine patients received an upgrading of the SD
valves because of symptoms of overdrainage. In six
patients, these symptoms resolved after upgrading. Howev-
er, a group of three patients was identified with persisting
symptoms of overdrainage in spite of the upgrading of the
valves. Replacement with various types of valves could not
solve these symptoms.
An alternative treatment option is an ETV with subse-
quent removal of the shunt regardless of the cause of the
hydrocephaly [1]. Two of our patients with persistent symp-
toms had the aetiology of intraventricular haemorrhage
(IVH) of prematurity with patent aqueducts. An ETV has
not been tried in these two patients. The third patient started
with an ETV for his triventricular hydrocephalus with aque-
ductal stenosis at the age of 4 months. The hydrocephalus
did not resolve, and a shunt was given. At the age of 3 years,
a second ETV was tried in order to treat the overdrainage
symptoms. Again, the ETV did not work sufficiently, and
another shunt was required.
We produced ‘head circumference for age’ curves for the
nine patients with symptoms of overdrainage. Four of the
nine patients presented with a normal head circumference at
the end of follow-up. Three of these four patients presented
with persistent symptoms of overdrainage despite the
upgrading of the valves. It is remarkable that the patients
with persistent symptoms presented with normal head cir-
cumference. The other five presented with head circumfer-
ences with a variation of more than 1 standard deviation
from the expected value at the end of follow-up: four with a
small head circumference and one with a large head circum-
ference. Unexpectedly, none of these patients presented with
persistent symptoms of overdrainage. All together, these
results do not show a clear association between a small head
circumference and persistent symptoms of overdrainage.
Table 1 Aetiology of
hydrocephalus Aetiology Total (n0100) 1A Symptomatic
(n09)
1B Non-symptomatic
(n010)
2 No upgrade
(n081)
Myelomeningocele 37 (37%) 1 (11.1%) 2 (20%) 34 (42%)
Aqueductal stenosis 13 (13%) 2 (22.2%) 1 (10%) 10 (12.3%)
Post-infectious 5 (5%) 0 0 5 (6.2%)
IVH of prematurity 17 (17%) 3 (33.3%) 2 (20%) 12 (14.8%)
Congenital communicating 3 (3%) 0 1 (10%) 2 (2.5%)
Posterior fossa cyst 6 (6%) 1 (11.1%) 2 (20%) 3 (3.7%)
Tumour (non-midbrain) 3 (3%) 0 0 3 (3.7%)
Other 16 (16%) 2 (22.2%) 2 (20%) 12 (14.8%)
Table 2 Characteristics of
groups Total (n0100) Group 1A (n09) Group 1B (n010) Group 2 (n081)
Male (%) 60 4 (44.4) 7 (70) 49 (60.5)
Procedure for hydrocephalus
prior to CSF shunt (%)
35 5 (55.6) 5 (50) 25 (30.9)
Revision within a year (%) 58 2 (22.2) 8 (80) 48 (59.3)
Total number of revisions;
mean (min/max)
2.36 (0/12) 6.56 (2/12) 4.5 (1/8) 1.69 (0/6)
Infection within a year (%) 15 1 (11.1) 4 (40) 10 (12.3)
Deceased (%) 11 0 (0) 1 (10) 10 (12.3)
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to be a risk factor for developing slit ventricle syndrome
with subsequent symptoms of overdrainage [5]. Only 3% (3
of 100) of the present cohort showed signs of a persistent
overdrainage syndrome. As is shown in Table 3, these three
patients with persistent overdrainage received initial CSF
shunt treatment at a mean of 88 postnatal days. For the
whole cohort, the mean time between birth and first inser-
tion of the CSF shunt was 54 days. It remains uncertain
whether there is a relation between the age of insertion
between these groups and the development of symptomatic
overdrainage.
Analysis according to hydrocephalus aetiology revealed
symptomatic overdrainage in only 1 of 37 myelomeningocele
patients. Neither the patients with communicating nor those
withpost-infectious hydrocephalus showed any signs of over-
drainage. We observed overdrainage most frequently in the
etiologic subgroup of children with IVH of prematurity, 3 out
of 17 patients. In our series, 2 out of 13 patients with aque-
ductal stenosis developed overdrainage. In one patient with
persisting symptoms of overdrainage, an ETV was performed
prior to the CSF shunt insertion. One may speculate whether
the failed ETV had an impact on the development of symp-
tomatic overdrainage during subsequent shunting with SD
low-pressure valves. The ETV that was performed prior to
the CSF shunt could have led to a situation where not only the
ventricles are being drained by the shunt but also the sub-
arachnoidspace.Thismayhaveresultedinreducedvolumeof
the subarachnoid space, which may have caused a further
disruption of CSF homeostasis.
Only two out of nine from group 1A (symptomatic)
needed a revision within a year after primary CSF shunt
surgery versus eight out of ten from group 1B (non-symp-
tomatic). The total number of revisions in group 1A and 1B
were, respectively, 6.6 and 4.5. This implies that the patients
in the symptomatic group (1A) started to develop shunt
dysfunction at a later age, but continued to require more
revisions after the first shunt dysfunction.
In our study, we found a 1-year shunt complication rate of
58%. In literature, rates of about 40% are found [7, 17]. This
might be explained by selection and size of our series. The
patients in our study were very young at first insertion of the
CSFshunt.Allpatientswereyoungerthan1yearofage,which
is reported as a risk factor for developing shunt failure [14].
Many other studies with a lower complication rate concern
‘children’ with ages up till the age of 18 years old [12, 13, 16].
An increased risk for a second shunt dysfunction was
present for patients with an early shunt dysfunction within
6 months after implantation. The risk of repeated revision in
this category was 76%. Shunts that were revised after
6 months after initial implantation had a 33% risk of repeat-
ed revision. For the next revision, we found similar numbers
(72% versus 50%). Similar results were found in literature.
The HR for the second and third episodes of shunt failure
that occurred within 6 months was approximately 1.5 times
that for failures that occurred after 6 months [8].
The infection rate in our study is 15% within the first year.
In literature, rates vary from 11.7% to 13.6% of the patients
with a range of 3–20% in a review [10, 13, 16]. Young age at
first implantation of a CSF shunt is a well-known risk factor
for CSF shunt infection [10]. Nevertheless, the infection rate
in our analysis of 100 patients is relatively high. Multiple
studies showed radical drops in infection rates after implica-
tion of shunt protocols [2, 9]. To improve outcomes in a
training hospital like ours, both infection surveillance and
implementation of protocols are requiring continuous atten-
tion. The mortality rate in our series is 11%. Comparable
figures can be found in the literature [15].
In spite of some limitations in this study, involving a
retrospective design and relatively small number of patients,
some interesting conclusions can be derived. First, the use of
SD low-pressure valves in the youngest age group appears to
be effective in the majority of patients. The aetiology of
myelomeningocele appears to protect the patient from symp-
tomatic overdrainage. The patients with persistent symptoms
despite the upgrading of the valves presented with normal
head circumference at the end of follow-up.
Fig. 1 First year shunt survival
Table 3 Age at first CSF shunt insertion in days
Age at first CSF shunt implantation
in days, mean (min/max)
Total 54 (1/318)
Group 1A
Whole (n09) 66 (19/187)
Problematic (n03) 88 (28/187)
Group 1B 54 (2/230)
Group 2 53 (1/318)
472 Childs Nerv Syst (2012) 28:469–473The findings of this study show a safe and effective use
of SD low valves in young children. Future studies compar-
ing implantation of alternative valves may indicate whether
SD low valves are superior or not.
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